Results 101 to 110 of about 43,229 (277)

High Prevalence of Active HDV Infection Among HBsAg‐Positive Patients in Urban and Rural Areas in Gabon: A Cross‐Sectional Retrospective Study

Health Science Reports, Volume 9, Issue 2, February 2026.
ABSTRACT Background HDV, a defective virus dependent on hepatitis B for assembly, can lead to severe liver diseases and an increased risk of progressing to complications such as hepatocellular carcinoma. Given the high prevalence of HDV in Gabon, especially in central Africa, understanding the epidemiology and associated risks is crucial.
Berthold Bivigou‐Mboumba, Michelle Bignoumba, Pamela Moussavou‐Boundzanga, Elsa‐Luce Missoni Manga, Amahani Gafou, Yann Mouanga Ndzime, Dorothée Marielle Wora, Larissa F. Akombi, Jovanie‐Dawen's Lendoye Zika Olembi, Rejane Manelle Betty Ndjila, Cyrille Bisseye, Augustin Mouinga Ondeme, Richard Onanga, Pascal Pineau   +13 more
wiley   +1 more source

PEG-INTERFERON ALPHA-2A AND LOW-DOSE RIBAVIRIN FOR TREATMENT OF HEPATITIS C VIRUS INFECTION IN PATIENTS WITH SICKLE CELL ANEMIA IN SAUDI ARABIA.

Mediterranean Journal of Hematology and Infectious Diseases, 2014
Introduction: Data regarding the safety and efficacy of antiviral therapy with pegylated interferon and ribavirin in patients with sickle cell disease and hepatitis C virus (HCV) infection are scanty.
Adnan Agha
doaj  

Clinical significance blood platelet count in patients with chronic hepatitis C on the background of the various options combined antiviral therapy

Журнал инфектологии, 2014
The purpose of this research is the study of the dynamics of platelet count in blood of patients with chronic hepatitis C on the background of the combined antiviral therapy with standard or pegylated interferon-α in combination with ribavirin.
K. V. Zhdanov, D. A. Gusev, K. V. Kozlov, A. V. Shekurov   +3 more
doaj   +1 more source

Role of antiviral therapy in the natural history of hepatitis B virus-related chronic liver disease [PDF]

, 2015
Hepatitis B virus (HBV) infection is a dynamic state of interactions among HBV, hepatocytes, and the host immune system. Natural history studies of chronic hepatitis B (CHB) infection have shown an association between active viral replication and adverse
Farinati, Fabio, Gottardo, G, Rodr\uedguez Castro, K, Russo, FRANCESCO PAOLO, Scribano, L, Vanin, V   +5 more
core   +1 more source

Type I interferons in tuberculosis: Foe and occasionally friend [PDF]

, 2018
Tuberculosis remains one of the leading causes of mortality worldwide, and, despite its clinical significance, there are still significant gaps in our understanding of pathogenic and protective mechanisms triggered by Mycobacterium tuberculosis infection.
Mayer-Barber, K, Moreira-Teixeira, L, O'Garra, A, Sher, A   +3 more
core   +1 more source

Ten‐Year Follow‐Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT‐II): Improved Clinical Outcome After Combination Therapy

United European Gastroenterology Journal, Volume 14, Issue 1, February 2026.
ABSTRACT Background Chronic delta hepatitis represents a major health burden. Until recently, pegylated interferon‐alfa‐2a (PEG‐IFNα) therapy was the only treatment option for patients infected with hepatitis D virus (HDV). The aim of this study was to evaluate 10‐year long‐term clinical and virological outcomes after 96 weeks of treatment with PEG ...
Cihan Yurdaydin, Julia Kahlhöfer, Florin Alexandru Caruntu, Kendal Yalcin, Selim Gürel, Ulus S. Akarca, Kathrin Sprinzl, Hans H. Bock, Jan‐Hendrik Bockmann, George V. Papatheodoridis, Uta Merle, Münevver Demir, Svenja Hardtke, Onur Keskin, Ramazan Idilman, Markus Cornberg, Heiner Wedemeyer, Anika Wranke   +17 more
wiley   +1 more source

Comparative Risk of Hepatitis B Virus Reactivation in Patients Receiving Immune Checkpoint Inhibitors or Tyrosine Kinase Inhibitors for Liver Cancer

Alimentary Pharmacology &Therapeutics, Volume 63, Issue 3, Page 383-395, February 2026.
In a cohort of 1596 liver cancer patients with either current or prior HBV infection undergoing systemic therapy in Hong Kong, the risk of HBV reactivation during immune checkpoint inhibitor treatment was low when adequate antiviral prophylaxis was administered, irrespective of HBV infection status.
Dorothy Cheuk‐Yan Yiu, Jimmy Che‐To Lai, Landon Long Chan, Grace Lai‐Hung Wong, Mandy Sze‐Man Lai, Vincent Wai‐Sun Wong, Yee‐Kit Tse, Henry Lik‐Yuen Chan, Stephen Lam Chan, Terry Cheuk‐Fung Yip   +9 more
wiley   +1 more source

De novo Cryoglobulinaemic Mononeuritis Multiplex during Treatment of Chronic Hepatitis C Infection: A Viral Effect or Induced by Pegylated Interferon Alpha

Case Reports in Gastroenterology, 2012
Cryoglobulinaemic mononeuritis multiplex (MNM) is an extrahepatic manifestation of chronic hepatitis C virus (HCV) infection for which interferon-based antiviral therapy is currently the treatment of choice.
J.R. Potts, S. Atkinson, J.A. Aram, J. Tibble, K.A. Davies, S. Verma   +5 more
doaj   +1 more source

The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report [PDF]

, 2009
Hepatitis C virus (HCV) genotypes 4, 5 and 6 represent >20% of all HCV cases worldwide. HCV-4 is mainly seen in Egypt, where it represents 90% of all HCV cases.
Antaki, N, CRAXI, Antonio, Dusheiko, G, Gadano, A, Haffar, S, Heathcote, EJ, Kamal, S, Lai, CL, Marcellin, P., Moucari, R, Pawlotsky, JM, Van der Merwe, S, Zein, N   +12 more
core   +1 more source

Efficacy and Safety of Adefovir Dipivoxil plus Pegylated Interferon-α2a for the Treatment of Lamivudine-Resistant Hepatitis B virus Infection in HIV-Infected Patients [PDF]

, 2008
Patrick Ingiliz, Marc‐Antoine Valantin, Vincent Thibault, Claudine Duvivier, Stéphanie Dominguez, Christine Katlama, Thierry Poynard, Yves Benhamou   +7 more
openalex   +1 more source